Cointime

Ra Pharmaceuticals

company

About

Ra Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules.

  • 5001 - 10000

Highlights

Total Funding Amount
$58.50M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$58.50M
Industries
Biotechnology,Medical,Pharmaceutical
Founded date
Jan 1, 2008
Number Of Employee
5001 - 10000
Operating Status
Active

Ra Pharma is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma is leveraging its ability to rapidly generate drug candidates to develop its own portfolio of products and partnerships focused on intracellular protein-protein interactions and other innovative approaches to addressing unmet medical needs.

It was founded in 2008 and headquartered in Cambridge, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$58.50M
Ra Pharmaceuticals has raised a total of $58.50M in funding over 2 rounds. Their latest funding was raised on Jul 23, 2015 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 23, 2015 Series B $58.50M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Ra Pharmaceuticals is funded by 1 investors. Limulus Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Limulus Venture Partners — Series B
Cointime
เนื้อหา
บริษัท